Information for Healthcare Professionals Prescribing or Dispensing Lenalidomide: This guide contains the info needed for the prescribing and dispensing of lenalidomide, including information about the Pregnancy Prevention Programme and important safety information. This guide ensures you know what to do before prescribing and dispensing lenalidomide. If lenalidomide is taken during pregnancy it is expected to cause severe birth defects or death to an unborn baby. This Programme is designed to make sure that unborn babies are not exposed to lenalidomide. It is a requirement of the Pregnancy Prevention Programme that all healthcare professionals (HCPs) ensure that they have read and understood the Healthcare Professionals Information guide before prescribing or dispensing lenalidomide for any patient. You must ensure that your patients fully understand what you have told them about lenalidomide and that they have completed the Treatment Initiation Form, before starting treatment.

This brochure contains information about: - Preventing harm to unborn babies. If lenalidomide is taken during pregnancy it is expected to cause severe birth defects or death to an unborn baby. - The Lenalidomide Pregnancy Prevention Programme, designed to ensure that unborn babies are not exposed to Lenalidomide. It will provide you with information about what to expect from your treatment, and explain the risks and your responsibilities. - Lenalidomide passes into men’s semen, and is expected to cause severe birth defects or death to an unborn baby. So there is a risk if you have unprotected sex with a woman who can become pregnant. - This brochure will help you understand what to do before, during and after taking lenalidomide. For your own health and safety, please read this brochure as well as the Package Leaflet that comes with your medicine, carefully. If you do not understand something, please ask your prescriber for further explanation.

Contains safety information regarding the risks to an unborn baby from Lenalidomide. Has information for the HCP to complete regarding treatment details and patient specifics (are they male or female, are they receiving counselling, contraception use). Contains emergency contact details.